Genzyme Tissue Repair (GZTR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair (GZTR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: SPSEIFERT who wrote (2004)	7/15/1998 10:20:00 AM
From: Caveat Emptor	of 2553

Info Sent to SEC/NASDR - Spinning Allegations intelico.com I have been involved with researching the venture funding of this company for some time. The focus is on compensation practices of the Investment Company/Venture Funding entitiy (Paine Webber et al), and certain executives of the companies they finance. Recently at the SEC Enforcement Division, a focus has been on this type of compensation, or "Spinning" as it is called. My fact patttern, developed via public document research has developed a fact pattern which I believe shows "questionable" patterns of compensation. This board, as well as others is dedicated to investors sharing information about their concerns about a stock. This shows major insider shifting of stock ownership as recently as 11/97. This type of shift, involving the Genzyme Development Partnership (as General Partners) I believe could effect the long and short term. The relationships between COmpany Officers/Directors and Insiders bothers me. Please review the posted material, and I will continue to monitor this board for questions and further information. CAVEAT EMPTOR

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next